LifeStance Health Group, Inc. (NASDAQ:LFST) Sees Significant Increase in Short Interest

LifeStance Health Group, Inc. (NASDAQ:LFST) was the target of a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 13,980,000 shares, an increase of 12.5% from the October 15th total of 12,430,000 shares. Based on an average daily volume of 871,400 shares, the days-to-cover ratio is presently 16.0 days. Approximately 19.7% of the shares of the company are sold short.

Insider Buying and Selling at LifeStance Health Group

In other LifeStance Health Group news, insider Warren Gouk sold 11,966 shares of the business’s stock in a transaction dated Thursday, August 31st. The stock was sold at an average price of $8.25, for a total transaction of $98,719.50. Following the sale, the insider now owns 5,856,262 shares in the company, valued at approximately $48,314,161.50. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other LifeStance Health Group news, insider Warren Gouk sold 11,966 shares of the company’s stock in a transaction on Thursday, August 31st. The shares were sold at an average price of $8.25, for a total value of $98,719.50. Following the sale, the insider now directly owns 5,856,262 shares of the company’s stock, valued at $48,314,161.50. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Kevin Michael Mullins sold 113,333 shares of the company’s stock in a transaction on Monday, October 2nd. The shares were sold at an average price of $6.61, for a total transaction of $749,131.13. Following the completion of the sale, the insider now directly owns 4,917,283 shares in the company, valued at $32,503,240.63. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 212,237 shares of company stock worth $1,389,099. 8.50% of the stock is currently owned by insiders.

Hedge Funds Weigh In On LifeStance Health Group

Institutional investors have recently added to or reduced their stakes in the stock. Janney Montgomery Scott LLC purchased a new position in LifeStance Health Group during the second quarter worth approximately $922,000. Keybank National Association OH purchased a new stake in shares of LifeStance Health Group during the 2nd quarter valued at approximately $176,000. Principal Financial Group Inc. raised its position in shares of LifeStance Health Group by 0.7% during the 2nd quarter. Principal Financial Group Inc. now owns 3,727,796 shares of the company’s stock valued at $34,035,000 after buying an additional 24,796 shares during the period. Arizona State Retirement System purchased a new stake in shares of LifeStance Health Group during the 2nd quarter valued at approximately $193,000. Finally, Olympiad Research LP purchased a new stake in shares of LifeStance Health Group during the 2nd quarter valued at approximately $98,000. Hedge funds and other institutional investors own 76.98% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, JPMorgan Chase & Co. increased their price target on shares of LifeStance Health Group from $9.00 to $10.00 and gave the stock a “neutral” rating in a report on Thursday, August 10th.

LifeStance Health Group Trading Down 1.4 %

Shares of NASDAQ:LFST opened at $6.12 on Thursday. LifeStance Health Group has a 1 year low of $4.22 and a 1 year high of $9.59. The firm has a market capitalization of $2.32 billion, a price-to-earnings ratio of -11.77 and a beta of 1.08. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.10 and a quick ratio of 1.10. The business’s 50 day moving average price is $6.34 and its 200-day moving average price is $7.76.

LifeStance Health Group (NASDAQ:LFST) last released its earnings results on Wednesday, November 8th. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.07) by ($0.10). The firm had revenue of $262.90 million during the quarter, compared to analysts’ expectations of $255.18 million. LifeStance Health Group had a negative net margin of 18.72% and a negative return on equity of 12.59%. The business’s revenue was up 20.8% compared to the same quarter last year. During the same quarter last year, the business earned ($0.11) EPS. On average, equities research analysts forecast that LifeStance Health Group will post -0.43 earnings per share for the current fiscal year.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.